‘Covishield’ the backbone of the Indian vaccination drive has officially been added to the United Kingdom’s list of recognized vaccines. The vaccine developed by British-Swedish company AstraZeneca and Oxford University is being manufactured by the Serum Institute of India (SII). The recognition will come into force from 4 a.m. on October 4. It was, however, told that the discussion on vaccination certificates is still on.
The change came the next day when Indian Foreign Minister S. Jaishankar and his British counterpart Liz Truss requested the U.K. to resolve the quarantine guidelines that require Indian travelers to the U.K. to be isolated for 10 days at home “irrespective of vaccination status”.
The U.K. govt. has informed that India that the problem wasn’t with the vaccine itself but rather with the vaccine certificates.
The U.K. High Commission officials said they were still in discussions “over-vaccination certifications with the Government of India”, indicating that a final decision on whether to include India in the list of recognized vaccine administrators has not yet been made.
The vaccine will have to be administered 14 days before traveling to the UK.